abnormal tumor morphology_Apc<Min>/Apc<+>,Glp2r<tm1Ddr>/Glp2r<tm1Ddr>

http://metadb.riken.jp/0003448IC57BL6JApcMinApcGlp2rtm1DdrGlp2rtm1DdrApcGlp2rtm1DdrApcMin

abnormal tumor morphology_Apc<Min>/Apc<+>,Glp2r<tm1Ddr>/Glp2r<tm1Ddr>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• glucagon-like peptide 2 receptor
  http://metadb.riken.jp/db/mgi_rdf/MGI:2136733
• adenomatosis polyposis coli
  http://metadb.riken.jp/db/mgi_rdf/MGI:88039

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Apc<Min>/Apc<+>,Glp2r<tm1Ddr>/Glp2r<tm1Ddr>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Apc<+>|Glp2r<tm1Ddr>|Apc<Min>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• altered tumor morphology
  http://purl.obolibrary.org/obo/MP_0003448

文献

http://purl.org/net/cito/citesAsAuthority

• Jacqueline A. Koehler, et.al., Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells., Cancer research, 2008, 68
  http://rdf.ncbi.nlm.nih.gov/pubmed/18829546